MarketPeel
Insider Trading Intelligence
Pricing
…
YR

Yadin Rozov

DAVE
DIRECTOR · DAVE INC./DE · CIK 0001921268
FILING MIX · LIFETIME53%/47%
BUYS
24
SELLS
21
TOTAL VALUE
$9.50M
COMPANIES
3
ACTIVE SINCE
May 2022
HOLDINGS NOW
600,662
AVG SELL PX
$54.23
TRADE KIND
SHOWING 45 / 45
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
26 backtested trades · 8 horizons · 34 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Yadin Rozov, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d26+23.08%+8.52%+1.16%+7.36%+8.69%—
14d26+57.69%+7.86%+1.65%+6.21%+3.32%—
30d26+50.00%+9.97%+2.49%+7.48%+0.91%—
60d26+38.46%+31.22%+4.83%+26.39%+17.49%—
90d26+57.69%+36.51%+6.06%+30.45%-1.17%—
180d26+65.38%+58.91%+7.55%+51.37%+1.93%—
1y26(15 pending)+81.82%+195.87%+20.70%+223.31%+128.76%—
2y26(19 pending)+100.00%+700.14%+41.34%+658.80%+363.30%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DAVE · 0 shares · as of Jun 5, 2026
025,57151,14276,712102,283202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 24 buys / 21 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DAVE
DAVE INC./DE
SALEGRANT
Gift
2,200——0Jun 5, 2026Jun 9, 2026 ↗View →
DAVE
DAVE INC./DE
PURCHASEGRANT
Stock grant
637——75,834Jun 2, 2026Jun 4, 2026 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASEGRANT
Stock grant
18,575——454,162Feb 4, 2026Feb 6, 2026 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
SALEGRANT
Gift
40,100——435,587Dec 30, 2025Jan 2, 2026 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASE
30,000$9.95$298.4K30,000Nov 12, 2025Nov 13, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
848$226.80$192.3K79,072Sep 12, 2025Sep 12, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
3$225.21$67679,920Sep 12, 2025Sep 12, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
822$228.64$187.9K75,788Sep 12, 2025Sep 12, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
591$229.75$135.8K75,197Sep 12, 2025Sep 12, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
2,462$227.90$561.1K76,610Sep 12, 2025Sep 12, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
1,659$195.79$324.8K92,924Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
228$203.99$46.5K79,923Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
1,384$202.86$280.8K80,151Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
800$197.95$158.4K91,112Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
2,327$201.10$468.0K82,131Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
3,619$199.90$723.4K84,458Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
1,012$196.94$199.3K91,912Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
3,035$198.98$603.9K88,077Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE10b5-1
10b5-1 plan
596$201.80$120.3K81,535Sep 4, 2025Sep 5, 2025 ↗View →
DAVE
DAVE INC./DE
PURCHASEGRANT
Gift
2,200——2,200Jun 10, 2025Jun 11, 2025 ↗View →
DAVE
DAVE INC./DE
SALEGRANT
Gift
2,200——94,583Jun 10, 2025Jun 11, 2025 ↗View →
DAVE
DAVE INC./DE
SALE
100$207.79$20.8K95,678Jun 4, 2025Jun 5, 2025 ↗View →
DAVE
DAVE INC./DE
SALE
5,400$206.92$1.12M95,778Jun 4, 2025Jun 5, 2025 ↗View →
DAVE
DAVE INC./DE
PURCHASEGRANT
Stock grant
1,105——102,283Jun 2, 2025Jun 6, 2025 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASE
110,000$10.87$1.20M475,687May 28, 2025May 29, 2025 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASEGRANT
Stock grant
20,448——365,687Jan 27, 2025Jan 28, 2025 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
SALE
105,000$18.11$1.90M345,239Nov 22, 2024Nov 22, 2024 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASE
195,000$0.01$1.9K450,239Nov 11, 2024Nov 12, 2024 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
SALE
195,000——0Nov 11, 2024Nov 12, 2024 ↗View →
DAVE
DAVE INC./DE
PURCHASEGRANT
Stock grant
4,726——101,178Jun 3, 2024Jun 5, 2024 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASEGRANT
Stock grant
47,793——255,239May 27, 2024May 28, 2024 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASEGRANT
Stock grant
127,446——207,446May 27, 2024May 28, 2024 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASE
105,000$2.52$264.7K195,000May 13, 2024May 15, 2024 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASE
80,000$3.07$246.0K80,000Mar 15, 2024Mar 18, 2024 ↗View →
CORZ
CORE SCIENTIFIC, INC./TX
PURCHASE
90,000$2.15$193.8K90,000Mar 15, 2024Mar 18, 2024 ↗View →
DAVE
DAVE INC./DE
PURCHASE
800$37.31$29.8K96,452Mar 7, 2024Mar 11, 2024 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
8,820——155,320Jan 4, 2024Jan 8, 2024 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
30,000——146,500Jan 4, 2024Jan 8, 2024 ↗View →
DAVE
DAVE INC./DE
PURCHASE
12,941$6.40$82.8K95,652Dec 4, 2023Dec 6, 2023 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
30,000——116,500Apr 17, 2023Apr 20, 2023 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASE
50,000$2.05$102.5K86,500Mar 14, 2023Mar 15, 2023 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASE
20,000$1.96$39.1K36,500Mar 13, 2023Mar 15, 2023 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
12,000——16,500Jul 28, 2022Aug 1, 2022 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
7,500——7,500May 2, 2022May 3, 2022 ↗View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
4,500——4,500May 2, 2022May 3, 2022 ↗View →
Other insiders · DAVE
Loading peer insiders…
About this filer
CIK 0001921268
ROLE
Director
PRIMARY
DAVE
COMPANIES
3
ACTIVE SINCE
May 2022
MARKETPEEL · /INSIDER/0001921268DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback